Further to the very recent posting on Angiotech's failed attempt to rescue its EP(UK) patent at the Court of Appeal, the IPKat's friend Richard Evans (whose ear must be close to the IP grindstone, if one will permit such mixed metaphors) notes that Angiotech have now succeeded in enforcing their EP(NL) version of the patent against Conor Medsystems (more brief info from ip world here). The Dutch District Court in the Hague had previously found the patent valid, contrary to the views of the High Court and Court of Appeal over here, and consequently found Conor to be infringing.
Conor apparently intend to appeal, so this is almost certainly not the end of the story.
Angiotech again
Reviewed by David Pearce
on
Thursday, January 18, 2007
Rating:
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html